Literature DB >> 22453173

Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Frédéric Checler1.   

Abstract

Cellular prion (PrP(c)) undergoes a regulated α-secretase-like cleavage by the disintegrin ADAM17 similar to the one taking place on β-amyloid precursor protein (βAPP). Because these cleavages give rise to biologically active fragments, understanding their regulation could be of importance. We have established that the Extracellular Regulated Kinase-1 (ERK1) controls PrPc processing by modulating ADAM17 phosphorylation in a protein kinase C-dependent manner. Strikingly, we also demonstrated that ERK1 acts upstream to increase PrP(c) promoter transactivation in an AP-1 dependent manner. Therefore, ERK1 exerts a dual control of both PrP(c) metabolism and expression. Interestingly, α-secretase cleavage of βAPP appears to be independent of ERK1. I describe here similarities and differences in α-secretase-mediated PrP(c) and βAPP processing pathways and discuss putative physiopathological implications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453173      PMCID: PMC3338960          DOI: 10.4161/pri.6.1.18004

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  25 in total

1.  The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation.

Authors:  Claire Sunyach; Moustapha Alfa Cisse; Cristine Alves da Costa; Bruno Vincent; Frédéric Checler
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

2.  Isoform-specific contribution of protein kinase C to prion processing.

Authors:  Moustapha Alfa Cissé; Krystel Louis; Uschi Braun; Bernard Mari; Michael Leitges; Barbara E Slack; Abraham Fisher; Patrick Auberger; Frédéric Checler; Bruno Vincent
Journal:  Mol Cell Neurosci       Date:  2008-07-29       Impact factor: 4.314

3.  The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Charlotte Druon; Sabine Scarzello; Frédéric Checler
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 5.  The prion hypothesis: from biological anomaly to basic regulatory mechanism.

Authors:  Mick F Tuite; Tricia R Serio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11-17       Impact factor: 94.444

Review 6.  Protein aggregation diseases: pathogenicity and therapeutic perspectives.

Authors:  Adriano Aguzzi; Tracy O'Connor
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 7.  Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.

Authors:  Tarek Boutros; Eric Chevet; Peter Metrakos
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

Review 8.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 9.  Physiology of the prion protein.

Authors:  Rafael Linden; Vilma R Martins; Marco A M Prado; Martín Cammarota; Iván Izquierdo; Ricardo R Brentani
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 10.  Prion protein: orchestrating neurotrophic activities.

Authors:  Vilma R Martins; Flavio H Beraldo; Glaucia N Hajj; Marilene H Lopes; Kil Sun Lee; Marco A Prado; Rafael Linden
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

View more
  1 in total

1.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.